1. Home
  2. AWH vs GNLN Comparison

AWH vs GNLN Comparison

Compare AWH & GNLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWH
  • GNLN
  • Stock Information
  • Founded
  • AWH 1993
  • GNLN 2005
  • Country
  • AWH United States
  • GNLN United States
  • Employees
  • AWH N/A
  • GNLN N/A
  • Industry
  • AWH Medical/Dental Instruments
  • GNLN Durable Goods
  • Sector
  • AWH Health Care
  • GNLN Consumer Discretionary
  • Exchange
  • AWH Nasdaq
  • GNLN Nasdaq
  • Market Cap
  • AWH 1.6M
  • GNLN 1.6M
  • IPO Year
  • AWH N/A
  • GNLN 2019
  • Fundamental
  • Price
  • AWH $0.11
  • GNLN $0.29
  • Analyst Decision
  • AWH Buy
  • GNLN
  • Analyst Count
  • AWH 2
  • GNLN 0
  • Target Price
  • AWH $4.40
  • GNLN N/A
  • AVG Volume (30 Days)
  • AWH 12.9M
  • GNLN 382.8K
  • Earning Date
  • AWH 03-27-2025
  • GNLN 03-21-2025
  • Dividend Yield
  • AWH N/A
  • GNLN N/A
  • EPS Growth
  • AWH N/A
  • GNLN N/A
  • EPS
  • AWH N/A
  • GNLN N/A
  • Revenue
  • AWH $9,182,000.00
  • GNLN $13,275,000.00
  • Revenue This Year
  • AWH $11.87
  • GNLN $1,541.21
  • Revenue Next Year
  • AWH $79.10
  • GNLN N/A
  • P/E Ratio
  • AWH N/A
  • GNLN N/A
  • Revenue Growth
  • AWH 0.31
  • GNLN N/A
  • 52 Week Low
  • AWH $0.08
  • GNLN $0.26
  • 52 Week High
  • AWH $3.63
  • GNLN $21.80
  • Technical
  • Relative Strength Index (RSI)
  • AWH 29.83
  • GNLN 18.77
  • Support Level
  • AWH $0.12
  • GNLN $0.26
  • Resistance Level
  • AWH $0.36
  • GNLN $0.37
  • Average True Range (ATR)
  • AWH 0.03
  • GNLN 0.06
  • MACD
  • AWH 0.01
  • GNLN 0.01
  • Stochastic Oscillator
  • AWH 9.00
  • GNLN 7.82

About AWH Aspira Women's Health Inc.

Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a distributor of vaporization products and consumption accessories in the United States. It offers a selection of stock-keeping units including vaporizers and parts, cleaning products, grinders and storage containers, pipes, rolling papers and customized lines of premium specialty packaging. The company markets and sells its products in both the business to business and business to consumer sectors of the marketplace. Its geographical segment includes the United States; Canada and Europe. It derives a majority of revenue from the United States.

Share on Social Networks: